Cortistatin-17 (human) trifluoroacetate salt

Modify Date: 2024-01-23 11:13:33

Cortistatin-17 (human) trifluoroacetate salt structure	Common Name	Cortistatin-17 (human) trifluoroacetate salt
	CAS Number	189450-19-9	Molecular Weight	2153.51000
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₉₆H₁₄₁N₂₇O₂₄S₃	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Cortistatin-17 (human) trifluoroacetate salt

Cortistatin-17 (human) is a somatostatin neuropeptide with potential for studying diseases such as cancer, inflammation, autoimmunity, fibrosis, and pain[1][2].

Name	cortistatin-17 (human)
Synonym	More Synonyms

Description	Cortistatin-17 (human) is a somatostatin neuropeptide with potential for studying diseases such as cancer, inflammation, autoimmunity, fibrosis, and pain[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> GPCR/G Protein >> Somatostatin Receptor Research Areas >> Inflammation/Immunology
References	[1]. Spier AD, et al. Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res Brain Res Rev. 2000 Sep;33(2-3):228-41. [2]. Campos-Salinas J, et al. Therapeutic Effect of a Latent Form of Cortistatin in Experimental Inflammatory and Fibrotic Disorders. Pharmaceutics. 2022 Dec 13;14(12):2785.

Description

Cortistatin-17 (human) is a somatostatin neuropeptide with potential for studying diseases such as cancer, inflammation, autoimmunity, fibrosis, and pain[1][2].

Related Catalog

Research Areas >> Cancer

Signaling Pathways >> GPCR/G Protein >> Somatostatin Receptor

Research Areas >> Inflammation/Immunology

References

[1]. Spier AD, et al. Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res Brain Res Rev. 2000 Sep;33(2-3):228-41.

[2]. Campos-Salinas J, et al. Therapeutic Effect of a Latent Form of Cortistatin in Experimental Inflammatory and Fibrotic Disorders. Pharmaceutics. 2022 Dec 13;14(12):2785.